chevron_leftBack
As of 6 June 2026, Arterra Bioscience S.p.A. has a market cap of $23.67M USD, ranking #35909 globally and #290 in Italy.
It ranks #3228 in the Healthcare sector, and #627 in the Biotechnology industry.
Key Stats
Market Cap
$23.67MUSD
20.37M EUR
Enterprise Value
$20.04MUSD
17.39M EUR
Revenue (TTM)
$4.85MUSD
4.17M EUR
EBITDA (TTM)
$1.97MUSD
1.71M EUR
Net Income (TTM)
$1.55MUSD
1.34M EUR
EBITDA Margin
41%
Profit Margin
32%
PE Ratio
15.2
PS Ratio
4.9
PB Ratio
1.8
EV/EBITDA
10.2
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Biotechnology
CEO
Maria Colucci
open_in_new
Employees
34
Founded
2003
Website
arterrabio.it
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 1% | -1.3% | 3% | -8.6% | -1% | 30% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
ARBS
Arterra Bioscience SpA Ordinary Shares
ISIN: IT0005386369
Shares Out.:
Shares Outstanding:
6.658M1
Shares Float:
2.076M2
|
3.09 EUR |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Arterra Bioscience S.p.A.
Arterra Bioscience S.p.A., a research-based biotech company, engages in the research and development of various ingredients and natural solutions. The company develops technological platforms, extraction processes, and raw materials for use in the cosmetics, agriculture, and nutraceutics sectors. Arterra Bioscience S.p.A. was founded in 2003 and is based in Napoli, Italy.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
MIL: UBM
|
$19.06M
-19%
16.41M EUR
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NASDAQ: AMGN
|
$182.42B
771K%
|
23.9
|
|
NASDAQ: GILD
|
$159.92B
676K%
|
19.0
|
|
EBR: ARGX
|
$48.08B
203K%
41.39B EUR
|
39.9
|
|
KRX: 207940
|
$44.48B
188K%
68.19T KRW
|
35.5
|
|
ASX: CSL
|
$43.01B
182K%
60.27B AUD
|
29.3
|
|
SIX: LONN
|
$42.72B
180K%
33.71B CHF
|
37.2
|
chevron_leftBack